SCHOTT Pharma AG & Co. KGaA Depreciation And Amortization for the year ending September 30, 2024: USD 72.35 M

SCHOTT Pharma AG & Co. KGaA Depreciation And Amortization is USD 72.35 M for the year ending September 30, 2024, a 31.97% change year over year. Depreciation and amortization are expense that reduces the value of tangible and intangible assets over their useful lives for tax and reporting purposes.
  • SCHOTT Pharma AG & Co. KGaA Depreciation And Amortization for the year ending September 30, 2023 was USD 54.82 M, a 1.05% change year over year.
  • SCHOTT Pharma AG & Co. KGaA Depreciation And Amortization for the year ending September 30, 2022 was USD 54.25 M, a 28.60% change year over year.
  • SCHOTT Pharma AG & Co. KGaA Depreciation And Amortization for the year ending September 30, 2021 was USD 42.19 M, a 6.73% change year over year.
  • SCHOTT Pharma AG & Co. KGaA Depreciation And Amortization for the year ending September 30, 2020 was USD 39.53 M.
Key Data
Date Depreciation And Amortization Dividends Paid Common Stock Issued Common Stock Repurchased